Chairman of the Federation of Indian Airlines (FIA) and Chairman of Kingfisher Airlines Limited, Vijay Mallaya on Saturday mentioned reducing service and connectivity if the central government did
Mumbai, June 12 : The deal in which Ranbaxy Laboratories Ltd India’s largest pharmaceutical company was sold off to a Japanese-based Daiichi Sankyo Co. has been appreciated by experts.
ChrysCapital Managing Director Sanjiv Kaul, an ex-Ranbaxy executive and a sector analyst said, “Commercially, it is an awesome deal. However, Ranbaxy was the all-conquering Indian hero and should have been the last man standing instead of being the first to capitulate. A huge positive for Ranbaxy but a negative for Indian pharma.”